As a result, using antioxidants to reduce ROS generation could be an effective strategy for lowering oxidative stress-related problems
The GOAL-HF1 trial (Randomized, Double-Blind, Multiple Ascending Dose, Placebo-Controlled, Multi-Center, Safety, Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Phase 1b/2a Clinical Trial With AC01 in Patients With Heart Failure With Reduced Ejection Fraction) is currently ongoing and is investigating the safety and effects of ghrelin
Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer
In recent years, a medication called semaglutide, primarily used for the treatment of type 2 diabetes and obesity, has shown promising results in lowering blood pressure